Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning / Rikus Knegtering en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning Tipo de documento: texto impreso Autores: Rikus Knegtering, Autor ; Stynke Castelein, Autor ; Han Bous, Autor Fecha de publicación: 2023 Artículo en la página: pp. 56-61 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona. Resumen: To compare sexual functioning in patients treated with quetiapine or risperidone.
This open-label study included patients with schizophrenia or a related psychotic illness who were randomized to quetiapine (200-1200 mg/d) or risperidone (1-6 mg/d) for 6 weeks. Sexual dysfunction was assessed by a semistructured interview, the Antipsychotics and Sexual Functioning Questionnaire (ASFQ), based upon the Utvalg for Kliniske Undersogelser (UKU).Link: ./index.php?lvl=notice_display&id=30979
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 56-61[artículo] A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning [texto impreso] / Rikus Knegtering, Autor ; Stynke Castelein, Autor ; Han Bous, Autor . - 2023 . - pp. 56-61.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 56-61
Palabras clave: Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona. Resumen: To compare sexual functioning in patients treated with quetiapine or risperidone.
This open-label study included patients with schizophrenia or a related psychotic illness who were randomized to quetiapine (200-1200 mg/d) or risperidone (1-6 mg/d) for 6 weeks. Sexual dysfunction was assessed by a semistructured interview, the Antipsychotics and Sexual Functioning Questionnaire (ASFQ), based upon the Utvalg for Kliniske Undersogelser (UKU).Link: ./index.php?lvl=notice_display&id=30979